Lantheus Medical Imaging Introduces Low-Enriched Uranium (LEU) TechneLite® Generator Read more about Lantheus Medical Imaging Introduces Low-Enriched Uranium (LEU) TechneLite® Generator
Lantheus Medical Imaging Announces Appointment of Jeffrey A. Bailey as New Chief Executive Officer Read more about Lantheus Medical Imaging Announces Appointment of Jeffrey A. Bailey as New Chief Executive Officer
Lantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier Read more about Lantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier
Lantheus Medical Imaging Announces Appointment of Cesare Orlandi, M.D., as New Chief Medical Officer Read more about Lantheus Medical Imaging Announces Appointment of Cesare Orlandi, M.D., as New Chief Medical Officer
Lantheus Medical Imaging Announces Molybdenum-99 Supply Contract with Institute for Radioelements Read more about Lantheus Medical Imaging Announces Molybdenum-99 Supply Contract with Institute for Radioelements
Lantheus Medical Imaging Focuses on Growth, Takes Steps to Reduce Expenses Read more about Lantheus Medical Imaging Focuses on Growth, Takes Steps to Reduce Expenses
Lantheus Medical Imaging to Host Fourth Quarter 2012 Conference Call on April 2, 2013 at 4:00 p.m. Eastern Time Read more about Lantheus Medical Imaging to Host Fourth Quarter 2012 Conference Call on April 2, 2013 at 4:00 p.m. Eastern Time
Lantheus Medical Imaging Realigns Executive Leadership Team Read more about Lantheus Medical Imaging Realigns Executive Leadership Team
Lantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ICNC 11th Annual Meeting Read more about Lantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ICNC 11th Annual Meeting
Lantheus Medical Imaging to Proceed with Flurpiridaz F 18 Phase 3 Clinical Program Based on Interim Analysis of Data from First Phase 3 Study Read more about Lantheus Medical Imaging to Proceed with Flurpiridaz F 18 Phase 3 Clinical Program Based on Interim Analysis of Data from First Phase 3 Study
